iShares Genomics Immunolo... (IDNA)
NYSEArca: IDNA
· 실시간 가격 · USD
39.29
-1.46 (-3.58%)
종가 기준: Aug 20, 2026, 3:59 PM
iShares Genomics Immunology and Healthcare ETF(IDNA) ETF 가격, 보유 종목 및 분석
-3.58% (1D)
| 매수호가 | 0 |
| 시가총액 | n/a |
| 운용자산 | 190.86M |
| 순자산가치 | 35.88 |
| 베타 | 1.12 |
| EPS (최근 12개월) | n/a |
| P/E (최근 12개월) | 25.25 |
| 발행 주식수 | n/a |
| 설정일 | Jun 11, 2019 |
| 매도호가 | 0 |
| 거래량 | 180,252 |
| 평균 거래량 (20일) | 52,264 |
| 시가 | 39.79 |
| 전일 종가 | 40.75 |
| 당일 변동폭 | 39.21 - 39.96 |
| 52주 변동폭 | 22.12 - 40.86 |
| 편입 종목 | n/a |
| 총보수 | 0.47% |
IDNA 정보
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-. The fund is non-diversified.
상위 10종목 자산의 43.01%
| 이름 | 종목코드 | 비중 |
|---|---|---|
| Bayer Ag | BAYN.DE | 4.80% |
| Twist Bioscience Cor... | TWST | 4.80% |
| Revolution Medicines... | RVMD | 4.56% |
| Regeneron Pharmaceut... | REGN | 4.35% |
| Incyte Corp | INCY | 4.23% |
| Genmab As | GMAB.CO | 4.21% |
| Moderna Inc | MRNA | 4.19% |
| Takeda Pharmaceutica... | 4502.T | 4.09% |
| Merck & Co Inc | MRK | 3.91% |
| Vertex Pharmaceutica... | VRTX | 3.87% |
배당 배당수익률 0.71%
| 배당락일 | 금액 | 지급일 |
|---|---|---|
| Jun 15, 2026 | $0.1250 | n/a |
| Dec 16, 2025 | $0.1550 | n/a |
| Jun 16, 2025 | $0.1530 | n/a |
| Dec 17, 2024 | $0.1110 | n/a |
| Jun 11, 2024 | $0.1110 | n/a |
